These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17150229)

  • 1. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling.
    Liao S; Porter D; Scott A; Newman G; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2007 Jan; 42(1):106-20. PubMed ID: 17150229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
    House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
    Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.
    Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction.
    Manning JR; Wijeratne AB; Oloizia BB; Zhang Y; Greis KD; Schultz JEJ
    J Mol Cell Cardiol; 2020 Nov; 148():1-14. PubMed ID: 32853649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.
    Manning JR; Perkins SO; Sinclair EA; Gao X; Zhang Y; Newman G; Pyle WG; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1382-96. PubMed ID: 23479264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2.
    House SL; Melhorn SJ; Newman G; Doetschman T; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H354-65. PubMed ID: 17337596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
    Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
    Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.
    Liao S; Bodmer J; Pietras D; Azhar M; Doetschman T; Schultz Jel J
    Dev Dyn; 2009 Feb; 238(2):249-64. PubMed ID: 18773489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection.
    Burt PM; Xiao L; Doetschman T; Hurley MM
    J Cell Physiol; 2019 Apr; 234(4):4418-4431. PubMed ID: 30144364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene targeted ablation of high molecular weight fibroblast growth factor-2.
    Azhar M; Yin M; Zhou M; Li H; Mustafa M; Nusayr E; Keenan JB; Chen H; Pawlosky S; Gard C; Grisham C; Sanford LP; Doetschman T
    Dev Dyn; 2009 Feb; 238(2):351-7. PubMed ID: 19105223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of sex differences in TNFR2-mediated cardioprotection.
    Wang M; Crisostomo PR; Markel TA; Wang Y; Meldrum DR
    Circulation; 2008 Sep; 118(14 Suppl):S38-45. PubMed ID: 18824767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade.
    House SL; Branch K; Newman G; Doetschman T; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2167-75. PubMed ID: 16040717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
    Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
    Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo.
    Milano G; Morel S; Bonny C; Samaja M; von Segesser LK; Nicod P; Vassalli G
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1828-35. PubMed ID: 17158645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection by polysaccharide sulfate against ischemia/reperfusion injury in isolated rat hearts.
    Yang Y; Hu SJ; Li L; Chen GP
    Acta Pharmacol Sin; 2009 Jan; 30(1):54-60. PubMed ID: 19098935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in rat myocardium associated with modulation of ischemic tolerance by diazoxide.
    Simoncíková P; Ravingerová T; Andelová E; Tribulová N; Barancík M
    Gen Physiol Biophys; 2007 Jun; 26(2):75-85. PubMed ID: 17660580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases. [corrected].
    Jiang ZS; Wen GB; Tang ZH; Srisakuldee W; Fandrich RR; Kardami E
    Can J Physiol Pharmacol; 2009 Oct; 87(10):798-804. PubMed ID: 19898562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.
    Qi D; Hu X; Wu X; Merk M; Leng L; Bucala R; Young LH
    J Clin Invest; 2009 Dec; 119(12):3807-16. PubMed ID: 19920350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.